Stock APVO APTEVO THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/05/2024 am IST 		5-day change 1st Jan Change
0.7107 USD -5.23% Intraday chart for Aptevo Therapeutics Inc. +5.62% -90.58%
11/04 US Equity Markets Close Mixed After March Producer Price Inflation Data MT
11/04 Top Midday Decliners MT

Chart calendar Aptevo Therapeutics Inc.

165452b.hutkE7jZcpcd0ss7Ec5ufcDTmOTzxvrJ6xxKs_VF47g.4pwNXeyBPsBauq0LQIMDMbni9IW-r6Krjl06xoAAj-LNuAVk8Zow51H_-w~ac15c18077b76c7904924004ef64b48d

Upcoming events on Aptevo Therapeutics Inc.

09/05/2024 Q1 2024 Earnings Release (Projected)
07/06/2024 Annual General Meeting
08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
26/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Aptevo Therapeutics Inc.

19/03/2024 03:00 am ROTH Conference
05/03/2024 06:35 pm Q4 2023 Earnings Release
05/02/2024 11:30 pm Extraordinary Shareholders Meeting
14/11/2023 06:35 pm Q3 2023 Earnings Release
07/11/2023 06:45 pm Bio-Europe Conference
10/08/2023 05:35 pm Q2 2023 Earnings Release
02/06/2023 10:30 pm Annual General Meeting
11/05/2023 05:35 pm Q1 2023 Earnings Release
30/03/2023 05:15 pm Q4 2022 Earnings Release
12/12/2022 American Society of Hematology Meeting - Poster No. APVO436
10/11/2022 06:35 pm Q3 2022 Earnings Release
11/08/2022 05:35 pm Interim 2022 Earnings Release
07/06/2022 10:30 pm Annual General Meeting
12/05/2022 05:35 pm Q1 2022 Earnings Release
12/04/2022 American Association of Cancer Research Meeting - Poster No : APVO442
24/03/2022 05:35 pm FY 2021 Earnings Release
12/11/2021 06:35 pm Q3 2021 Earnings Release
28/10/2021 Euroleuk Congress
12/08/2021 05:35 pm Interim 2021 Earnings Release
19/07/2021 08:55 pm Cambridge Health Institute PEGS Virtual Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		32,4
33,1
-2.15%		4,31
3,68
17.07%		12,3
12,0
2.2%		3,11
3,11
0%		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-42,6
-46,1
7.55%		-27,5
-27,2
-1.21%		-21,4
-22,5
4.93%		-28,6
-29,0
1.08%		-28,9
-29,2
1.18%
-25,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-44,7
-47,0
4.83%		-30,9
-25,9
-19.42%		-29,4
-28,8
-1.96%		7,01
4,36
60.78%		-18,7
-18,0
-3.8%
-25,9

Net income
Million USD		Released
Forecast
Spread 		-40,4
-45,2
10.54%		-17,8
-16,8
-5.96%		-28,5
-28,8
1.33%		8,03
4,71
70.48%		-17,4
-18,2
4.27%
-25,7

EPS
USD		Released
Forecast
Spread 		-610
-698
12.65%		-230
-201
-14.57%		-267
-270
1.14%		69,1
40,9
68.82%		-62,5
-75,5
17.2%
-20,2

Announcement Date25/03/2031/03/2124/03/2230/03/2305/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		3,67
3,40
7.79%		3,11
3,75
-16.96%		0,00
3,43
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-4,04
-5,15
21.55%		-5,61
-4,57
-22.83%		-7,56
-5,88
-28.67%		-7,78
-7,59
-2.58%		-7,68
-8,00
3.93%		-7,76
-7,97
2.73%		-8,18
-8,00
-2.23%		-6,56
-8,91
26.4%		-6,38
-6,73
5.13%
-6,42


-6,45


-6,48


-6,51

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-6,60
-6,45
-2.29%		-7,88
-6,26
-25.89%		27,9
-5,53
603.91%		-7,81
-8,50
8.13%		-5,16
-8,06
35.95%		1,83
-7,92
123.06%		-7,95
-8,00
0.65%		-6,33
-8,48
25.29%		-6,20
-6,46
4.06%
-6,42


-6,45


-6,48


-6,51

Net income
Million USD		Released
Forecast
Spread 		-6,27
-6,45
2.75%		-7,70
-6,26
-23.04%		28,0
-5,53
606.6%		-7,64
-8,35
8.46%		-4,64
-7,96
41.69%		2,77
-7,82
135.44%		-7,95
-8,00
0.65%		-6,33
-8,86
28.54%		-5,90
-6,68
11.62%
-6,42


-6,45


-6,48


-6,51

EPS
USD		Released
Forecast
Spread 		-55,9
-57,0
1.93%		-68,2
-40,9
-66.67%		246
-48,8
602.7%		-66,0
-72,2
8.54%		-41,8
-67,3
37.91%		17,2
-52,1
132.91%		-54,1
-49,3
-9.82%		-22,0
-33,0
33.33%		-6,16
-18,0
65.85%
-12,8


-6,53


-3,90


-3,84

Announcement Date24/03/2212/05/2211/08/2210/11/2230/03/2311/05/2310/08/2314/11/2305/03/24----

Upcoming sector events for Aptevo Therapeutics Inc.

01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 04:30 pm NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
02/05/2024 01:35 am SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
More events

Past sector events for Aptevo Therapeutics Inc.

Today 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
Today DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
Today MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 04:30 pm WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
29/04/2024 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release
29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. APVO Stock
  4. Calendar Aptevo Therapeutics Inc.